Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
[Online ahead of print]

Senescence-induced Inflammation: An Important Player and Key Therapeutic Target in Atherosclerosis

Affiliations

Senescence-induced Inflammation: An Important Player and Key Therapeutic Target in Atherosclerosis

Stevan D Stojanović et al. Eur Heart J.

Abstract

Inflammation is a hallmark and potent driver of pathological vascular remodelling in atherosclerosis. However, current anti-inflammatory therapeutic strategies have shown mixed results. As an alternative perspective on the conundrum of chronic inflammation emerging evidence points towards a small subset of senescent cells as a critical player and central node driving atherosclerosis. Senescent cells belonging to various cell types are a dominant and chronic source of a large array of pro-inflammatory cytokines and various additional plaque destabilizing factors, being involved with various aspects of atherosclerosis pathogenesis. Antagonizing these key agitators of local chronic inflammation and plaque instability may provide a causative and multi-purpose therapeutic strategy to treat atherosclerosis. Anti-senescence treatment options with translational potential are currently in development. However, several questions and challenges remain to be addressed before these novel treatment approaches may enter the clinical setting.

Keywords: Ageing; Atherosclerosis; Cardiovascular disease; Inflammation; Vascular disease.

Similar articles

See all similar articles

LinkOut - more resources

Feedback